MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.

MLA

Filocamo, Gessica, et al. “MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.” Molecular Cancer Therapeutics, vol. 15, no. 6, June 2016, pp. 1177–89. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-15-0371.

APA

Filocamo, G., Brunetti, M., Colaceci, F., Sasso, R., Tanori, M., Pasquali, E., Alfonsi, R., Mancuso, M., Saran, A., Lahm, A., Di Marcotullio, L., Steinkühler, C., & Pazzaglia, S. (2016). MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma. Molecular Cancer Therapeutics, 15(6), 1177–1189. https://doi.org/10.1158/1535-7163.MCT-15-0371

Chicago

Filocamo, Gessica, Mirko Brunetti, Fabrizio Colaceci, Romina Sasso, Mirella Tanori, Emanuela Pasquali, Romina Alfonsi, et al. 2016. “MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.” Molecular Cancer Therapeutics 15 (6): 1177–89. doi:10.1158/1535-7163.MCT-15-0371.